Select committee: Health and Social Care Committee

Recommendation 23

Second Report - The impact of body image on mental and physical health Published 2 Aug 2022 Paragraph 123 Addressed to Department of Health and Social Care
Recommendation (the committee's words)
We recommend that the Department review the licencing of dermal fillers to be prescription-only substances, in line with Botox, in order to provide more protection for people undertaking procedures involving dermal fillers.

From: Health and Social Care Committee, Second Report - The impact of body image on mental and physical health (HC 114), paragraph 123, 2 August 2022

Government response

The government responded to the whole report on 7 February 2023 (deadline 2 October 2022).

Summary written by Accountability Index from the government's response. It is not the government's own words.

The government "strongly agrees" there is a need for cross-government work on body image, but says there is not an immediate need for a standalone strategy and that it will not meet the committee's timeline for licensing non-surgical cosmetic procedures.

  • On eating disorders, it expects them to be considered within the major conditions strategy (interim report due in the summer), so "does not intend to publish a separate national eating disorder strategy". It accepts the research part of the recommendation.
  • It agrees that diagnosis and treatment of body dysmorphic disorder (BDD) is a priority, but says this is "best achieved through the current training, referral routes and curriculum".
  • On non-surgical cosmetic procedures, it is taking forward a licensing scheme but says it "will not be able to meet the timeline recommended by the committee". DHSC will agree the procedures in scope and communicate a plan for delivery by July 2023.
  • On screen time, it says much more research is needed before national guidance. DHSC will work with DCMS and DfE on gathering evidence "before deciding whether to progress with a nationwide public health campaign", which would be contingent on future funding settlements.

Read the government's response ↗ Report an error